| Karan Rajesh Vyas, MD | |
|
4420 Lake Boone Trl, Raleigh, NC 27607-7505 | |
| (919) 784-3100 | |
| Not Available |
| Full Name | Karan Rajesh Vyas |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 13 Years |
| Location | 4420 Lake Boone Trl, Raleigh, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023404746 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rex Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rex Hospital Inc | 0840109864 | 652 |
News Archive
The number of shoulder replacement surgeries has skyrocketed nationally and at Loyola University Medical Center as technology improves and aging Baby Boomers seek to relieve pain and restore function to arthritic shoulders.
Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED) gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.
Farmers markets at medical centers may contribute to greater wellness in surrounding communities while adding public health value to a market's mission, say Penn State College of Medicine researchers who have developed and evaluated a market created at Penn State Milton S. Hershey Medical Center.
Advaxis, Inc., (OTCQB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated anal cancer.
Organovo, Inc., a regenerative medicine company focused on bioprinting technology, today announced the release of data on the first fully bioprinted blood vessels. Data was presented at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) meeting in Orlando, Florida. The blood vessels were created through the use of the NovoGen MMX Bioprinter, Organovo's proprietary platform for the creation of 3D tissue constructs.
› Verified 5 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
The number of shoulder replacement surgeries has skyrocketed nationally and at Loyola University Medical Center as technology improves and aging Baby Boomers seek to relieve pain and restore function to arthritic shoulders.
Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED) gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.
Farmers markets at medical centers may contribute to greater wellness in surrounding communities while adding public health value to a market's mission, say Penn State College of Medicine researchers who have developed and evaluated a market created at Penn State Milton S. Hershey Medical Center.
Advaxis, Inc., (OTCQB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated anal cancer.
Organovo, Inc., a regenerative medicine company focused on bioprinting technology, today announced the release of data on the first fully bioprinted blood vessels. Data was presented at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) meeting in Orlando, Florida. The blood vessels were created through the use of the NovoGen MMX Bioprinter, Organovo's proprietary platform for the creation of 3D tissue constructs.
› Verified 5 days ago
| Entity Name | Rex Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144248683 PECOS PAC ID: 0840109864 Enrollment ID: O20140613001181 |
News Archive
The number of shoulder replacement surgeries has skyrocketed nationally and at Loyola University Medical Center as technology improves and aging Baby Boomers seek to relieve pain and restore function to arthritic shoulders.
Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED) gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.
Farmers markets at medical centers may contribute to greater wellness in surrounding communities while adding public health value to a market's mission, say Penn State College of Medicine researchers who have developed and evaluated a market created at Penn State Milton S. Hershey Medical Center.
Advaxis, Inc., (OTCQB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated anal cancer.
Organovo, Inc., a regenerative medicine company focused on bioprinting technology, today announced the release of data on the first fully bioprinted blood vessels. Data was presented at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) meeting in Orlando, Florida. The blood vessels were created through the use of the NovoGen MMX Bioprinter, Organovo's proprietary platform for the creation of 3D tissue constructs.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karan Rajesh Vyas, MD 1908 Rolling Rd, Chapel Hill, NC 27514-7504 Ph: (727) 510-3697 | Karan Rajesh Vyas, MD 4420 Lake Boone Trl, Raleigh, NC 27607-7505 Ph: (919) 784-3100 |
News Archive
The number of shoulder replacement surgeries has skyrocketed nationally and at Loyola University Medical Center as technology improves and aging Baby Boomers seek to relieve pain and restore function to arthritic shoulders.
Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED) gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.
Farmers markets at medical centers may contribute to greater wellness in surrounding communities while adding public health value to a market's mission, say Penn State College of Medicine researchers who have developed and evaluated a market created at Penn State Milton S. Hershey Medical Center.
Advaxis, Inc., (OTCQB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated anal cancer.
Organovo, Inc., a regenerative medicine company focused on bioprinting technology, today announced the release of data on the first fully bioprinted blood vessels. Data was presented at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) meeting in Orlando, Florida. The blood vessels were created through the use of the NovoGen MMX Bioprinter, Organovo's proprietary platform for the creation of 3D tissue constructs.
› Verified 5 days ago
John O Collins, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4420 Lake Boone Trl, Raleigh, NC 27607 Phone: 919-784-7093 Fax: 919-784-7395 | |
Dr. Kenneth M Carnes, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1540 Sunday Dr, Raleigh, NC 27607 Phone: 919-782-3456 Fax: 919-787-7552 | |
Dr. Jane Mcnab Deveau, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3305 Sungate Blvd, Raleigh Cboc - Vamc, Raleigh, NC 27610 Phone: 919-212-0129 | |
Laura Catherine Politte, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 23 Sunnybrook Rd, Raleigh, NC 27610 Phone: 919-235-6510 Fax: 919-231-0314 | |
Marjorie L. Carlstein, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3937 Western Blvd, Raleigh, NC 27606 Phone: 919-821-0790 Fax: 919-518-9476 | |
Brian Vernon Robbins, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 111 Sunnybrook Rd, Raleigh, NC 27610 Phone: 919-250-1260 | |
Dr. Charles Michel Lavigne, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4420 Lake Boone Trl, Raleigh, NC 27607 Phone: 919-784-7093 |